Acrobiosystems Co.,Ltd. (SHE:301080)
China
· Delayed Price · Currency is CNY 43.63
-1.37 (-3.04%)
Mar 9, 2026, 4:00 PM EDT
Acrobiosystems Revenue
Acrobiosystems had revenue of 225.62M CNY in the quarter ending September 30, 2025, with 37.50% growth. This brings the company's revenue in the last twelve months to 794.52M, up 33.63% year-over-year. In the year 2024, Acrobiosystems had annual revenue of 645.02M with 18.65% growth.
Revenue (ttm)
794.52M
Revenue Growth
+33.63%
P/S Ratio
9.19
Revenue / Employee
914.29K
Employees
869
Market Cap
7.30B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 950.29M |
| Zhejiang Ausun Pharmaceutical | 751.12M |
| Suzhou Fengbei Biotech Stock | 2.81B |
| Jiangsu Aidea Pharmaceutical Group | 720.67M |
| Anhui Huaheng Biotechnology | 2.89B |
| Nanjing Vazyme Biotech | 1.38B |
| Chengdu Kanghua Biological Products | 1.21B |
| Jiangxi Fushine Pharmaceutical | 970.32M |